On September 3, 2019, AmCham Germany's Healthcare & Life Sciences Committee met with Martin Weiland, Federal Chancellery, for a discussion on current healthcare policies. Amongst the issues touched on were pharmaceutical and medical device policies and regulations. In addition, digitalization and innovation in the healthcare sector as well as the transatlantic partnership with regard to healthcare-related issues were part of the lively and open exchange with Martin Weiland.
Topics: Pharmaceutical and Medical Device Policies, Digitalization and the Transatlantic Healthcare Sector